In the US, Sirolimus (sirolimus systemic) is a member of the following drug classes: mTOR inhibitors, selective immunosuppressants and is used to treat Lymphangioleiomyomatosis and Organ Transplant - Rejection Prophylaxis.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
- Sirolimusum (Latin)
- Sirolimus (German)
- Sirolimus (French)
- Sirolimus (Spanish)
- Sirolimus (OS: BAN, USAN, DCF)
- AY-22989 (IS: Wyeth)
- NSC-226080 (IS)
- NSC-606698 (IS)
- Rapamune (IS)
- Rapamycin (IS)
- WY-090217 (IS: Wyeth)
Astellas, South Korea; Patheon, Israel; Pfizer, Argentina; Pfizer, Austria; Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Czech Republic; Pfizer, Germany; Pfizer, Denmark; Pfizer, Ecuador; Pfizer, Egypt; Pfizer, Spain; Pfizer, Finland; Pfizer, France; Pfizer, United Kingdom; Pfizer, Greece; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Ireland; Pfizer, Iceland; Pfizer, Malaysia; Pfizer, Netherlands; Pfizer, Norway; Pfizer, New Zealand; Pfizer, Philippines; Pfizer, Poland; Pfizer, Portugal; Pfizer, Serbia; Pfizer, Sweden; Pfizer, Singapore; Pfizer, Slovakia; Pfizer, Tunisia; Pfizer, Turkey; Pfizer, Taiwan; Pfizer, South Africa; Pfizer Italia, Italy; Wyeth, Brazil; Wyeth, Chile; Wyeth, Greece; Wyeth, Latvia; Wyeth, Oman; Wyeth, Romania; Wyeth, Serbia; Wyeth, Tunisia; Wyeth Medica, Lithuania; Wyeth Pharmaceutical Co Ltd, China; Wyeth, Inc., United States
- Rui Pa Ming
Kerui Pharmaceutical, China
Huadong Pharmaceutical Group, China
Complex Therapeutics, Chile
NCPC GeneTech, China
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|IUPAC||International Union of Pure and Applied Chemistry|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.